Trading Market Rules. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. Except as set forth in Schedule 3.S, the issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. Subject to acceptance of the notice of the Placement by the Toronto Stock Exchange and the NASDAQ Global Market, the issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the OTC Bulletin Board.
Trading Market Rules. The issuance and sale of the Securities hereunder complies in all material respects with the rules and regulations of the Trading Market.
Trading Market Rules. Subject to acceptance of the notice of the Offering by the NASDAQ Global Market on or before the Closing, the issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market. Cell Therapeutics, Inc. December 20, 2007
Trading Market Rules. Subject to the final approval for listing of the TSX and the NYSE Amex, the issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. Assuming the accuracy of the certificate of the Placement agent, the issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
Trading Market Rules. Due to the timing of the anticipated execution of purchase agreements with investors, BioSante will not comply with the requirement to file a Notice of Listing of Additional Shares notification with NASDAQ at least 15 days prior to the anticipated issuance of Securities. Schedule 3(V)
